Key Financial Inc’s Alaunos Therapeutics TCRT Stock Holding History

Key Financial Inc’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54	Hold	24	–	–	﹤0.01%	1335
2026 Q1	$69	Hold	24	–	–	﹤0.01%	1371
2025 Q4	$78	Hold	24	–	–	﹤0.01%	1417
2025 Q3	$60	Hold	24	–	–	﹤0.01%	1440
2025 Q2	$116	Buy	+24	New	+$72	﹤0.01%	1395
2024 Q3	–	Sell	-25	Closed	-$171	–	1364
2024 Q2	$171	Hold	25	–	–	﹤0.01%	1298
2024 Q1	$443	Hold	25	–	–	﹤0.01%	1237
2023 Q4	$261	Hold	25	–	–	﹤0.01%	1270
2023 Q3	$486	Hold	25	–	–	﹤0.01%	1251
2023 Q2	$1.88K	Hold	25	–	–	﹤0.01%	1170
2023 Q1	$2.32K	Hold	25	–	–	﹤0.01%	937
2022 Q4	$6.34K	Hold	25	–	–	﹤0.01%	738
2022 Q3	$6K	Hold	25	–	–	﹤0.01%	769
2022 Q2	$5K	Hold	25	–	–	﹤0.01%	814
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	948
2021 Q4	$4K	Hold	25	–	–	﹤0.01%	757
2021 Q3	$7K	Hold	25	–	–	﹤0.01%	662
2021 Q2	$8K	Hold	25	–	–	﹤0.01%	624
2021 Q1	$13K	Hold	25	–	–	0.01%	458
2020 Q4	$9K	Buy	+25	New	+$9.94K	0.01%	478
2020 Q2	–	Sell	-25	Closed	-$9K	–	562
2020 Q1	$9K	Buy	+25	New	+$12.9K	0.01%	424

Other funds holding TCRT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

WPA

West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Key Financial Inc's TCRT Position: Q2 2026 in Review

Key Financial Inc held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 24 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Key Financial Inc first reported a position in TCRT in Q1 2020 and has held it in 21 quarters since. The position peaked at $13K in Q1 2021. 7 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

Key Financial Inc held 24 shares of Alaunos Therapeutics worth $54 as of Q2 2026.
Key Financial Inc left its Alaunos Therapeutics share count unchanged in Q2 2026.
Alaunos Therapeutics made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1335 holding.
Key Financial Inc first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 21 quarters since.
Key Financial Inc's Alaunos Therapeutics position peaked at $13K in Q1 2021.
7 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.